These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21616691)

  • 1. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.
    Bolenz C; Gupta A; Hotze T; Ho R; Cadeddu JA; Roehrborn CG; Lotan Y
    Eur Urol; 2010 Mar; 57(3):453-8. PubMed ID: 19931979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization costs for radical prostatectomy attributable to robotic surgery.
    Kim SP; Shah ND; Karnes RJ; Weight CJ; Shippee ND; Han LC; Boorjian SA; Smaldone MC; Frank I; Gettman MT; Tollefson MK; Thompson RH
    Eur Urol; 2013 Jul; 64(1):11-6. PubMed ID: 22959352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy.
    Tomaszewski JJ; Matchett JC; Davies BJ; Jackman SV; Hrebinko RL; Nelson JB
    Urology; 2012 Jul; 80(1):126-9. PubMed ID: 22608294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.
    Manoharan M; Eldefrawy A; Katkoori D; Antebi E; Soloway MS
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):307-10. PubMed ID: 20838414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
    Punnen S; Meng MV; Cooperberg MR; Greene KL; Cowan JE; Carroll PR
    BJU Int; 2013 Aug; 112(4):E314-20. PubMed ID: 23451984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
    Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
    BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.
    Mouraviev V; Nosnik I; Sun L; Robertson CN; Walther P; Albala D; Moul JW; Polascik TJ
    Urology; 2007 Feb; 69(2):311-4. PubMed ID: 17320670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
    Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
    J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cost structures and the economics of robot assisted radical prostatectomy.
    Scales CD; Jones PJ; Eisenstein EL; Preminger GM; Albala DM
    J Urol; 2005 Dec; 174(6):2323-9. PubMed ID: 16280833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.
    Briganti A; Bianchi M; Sun M; Suardi N; Gallina A; Abdollah F; Bertini R; Colombo R; Girolamo VD; Salonia A; Scattoni V; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 Jun; 111(8):1222-30. PubMed ID: 23145532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience.
    Silverstein AD; Weizer AZ; Dowell JM; Auge BK; Paulson DF; Dahm P
    Urology; 2004 Apr; 63(4):746-50. PubMed ID: 15072893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
    González-San Segundo C; Herranz-Amo F; Alvarez-González A; Cuesta-Álvaro P; Gómez-Espi M; Paños-Fagundo E; Santos-Miranda JA
    Ann Surg Oncol; 2011 Oct; 18(10):2980-7. PubMed ID: 21431406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
    Krambeck AE; DiMarco DS; Rangel LJ; Bergstralh EJ; Myers RP; Blute ML; Gettman MT
    BJU Int; 2009 Feb; 103(4):448-53. PubMed ID: 18778350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer.
    Corcoran AT; Peele PB; Benoit RM
    Urology; 2010 Sep; 76(3):703-7. PubMed ID: 20381846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.